BridgeMD
New treatment option for Autism
Official title Parent-Mediated Social Cognition Intervention for Young Children With Autism Spectrum Disorder
ClinicalTrials.gov ID: NCT07708246
What this study is testing
- What it's testing
- This study evaluates the efficacy of the Companion Mind-Drawing Cooperative Game Program, a parent-mediated, home-based structured play intervention targeting social cognitive development in young children with autism spectrum disorder (ASD). Children with ASD in the intervention group will receive a structured program in which parents attend an in-person training session (approximately 2.5 hours) at the hospital, where parents are taught to administer a series of researcher-designed cooperative game paradigms at home.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 4 to 8
You may be able to join if
- Children：
- Aged 2.5 to 14 years at time of enrollment, with a primary recruitment focus on children aged 3 to 10 years.
- Meets diagnostic criteria for autism spectrum disorder (ASD) according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition...
- Full-scale intelligence quotient (FSIQ) ≥ 70 as assessed by an age-appropriate Wechsler intelligence scale administered.
- Possesses sufficient verbal ability to engage with structured play-based intervention activities, as judged by the recruiting clinician.
You likely can't join if
- Children：
- Known diagnosis of a genetic syndrome associated with ASD or intellectual disability, including but not limited to Fragile X syndrome, Down syndrome...
- Presence of a neurological disorder, including epilepsy (unless fully controlled with stable medication for ≥ 12 months), acquired brain injury...
- Uncorrected vision or hearing impairment that would preclude participation in behavioral or eye-tracking assessments.
- Currently enrolled in another treatment clinical study targeting social cognition, communication, or behavioral outcomes.
- Any medical, psychiatric, or developmental condition that, in the opinion of the recruiting clinician, would interfere with the child's ability to...
See the full eligibility criteria
Who can join
- Children：
- Aged 2.5 to 14 years at time of enrollment, with a primary recruitment focus on children aged 3 to 10 years.
- Meets diagnostic criteria for autism spectrum disorder (ASD) according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), confirmed by a specialist clinician.
- Full-scale intelligence quotient (FSIQ) ≥ 70 as assessed by an age-appropriate Wechsler intelligence scale administered.
- Possesses sufficient verbal ability to engage with structured play-based intervention activities, as judged by the recruiting clinician.
- Resides with and is cared for by a participating parent or legal guardian who meets the caregiver eligibility criteria below. Caregiver：
- Is the primary caregiver (parent or legal guardian) of the enrolled child and resides in the same household.
- Is able and willing to attend an in-person parent training session (approximately 2.5 hours) at the study site prior to intervention commencement.
- Is able and willing to commit to administering the structured intervention program to the child for a minimum of 30 minutes per day throughout the 6-month intervention period.
- Is able and willing to participate in monthly online video supervision sessions with the study clinician.
- Has sufficient literacy and comprehension ability to understand program training materials and follow intervention procedures.
- Provides written informed consent on behalf of the child and for their own participation prior to any study procedures.
What rules you out
- Children：
- Known diagnosis of a genetic syndrome associated with ASD or intellectual disability, including but not limited to Fragile X syndrome, Down syndrome, tuberous sclerosis complex, or Rett syndrome.
- Presence of a neurological disorder, including epilepsy (unless fully controlled with stable medication for ≥ 12 months), acquired brain injury, cerebral palsy, or other significant neurological condition that may...
- Uncorrected vision or hearing impairment that would preclude participation in behavioral or eye-tracking assessments.
- Currently enrolled in another treatment clinical study targeting social cognition, communication, or behavioral outcomes.
- Any medical, psychiatric, or developmental condition that, in the opinion of the recruiting clinician, would interfere with the child's ability to participate in or benefit from the intervention. Caregiver：
- Unable to attend the in-person parent training session at the study site due to geographic, occupational, or other constraints.
- Unable to commit to the daily home-based intervention schedule or monthly online supervision sessions for the full 6-month intervention period.
- Presence of significant mental health difficulties or other circumstances that, in the opinion of the recruiting clinician, would substantially impair the caregiver's ability to deliver the intervention with adequate...
The study team makes the final eligibility decision.
Where it's taking place
- Shanghai, Shanghai Municipality, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 4 years to 8 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Shanghai, Shanghai Municipality, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.